Table 1.

Clinical characteristics of PNH+ and PNH- patients




PNH+

PNH-

P
No. of patients   83   39   NA  
Median age, y (range)   57 (13-83)   54 (12-83)   .16  
Sex, M/F   36/47   19/20   .58  
Severity, severe/moderate   53/30   22/17   .43  
Chromosome abnormality, no. of patients  7   3   .88  
   –7   0   1   
   +8   2   1   
   –Y   3   0   
   Others   2   1   
Median WBC count, × 109 (range)   2.1 (0.5-4.3)   1.9 (0.7-3.2)   .15  
Median neutrophil count, × 109/L (range)   0.53 (0.02-2.2)   0.49 (0.01-2.7)   .65  
Median hemoglobin level, g/L (range)   67 (32-140)   67 (40-108)   .92  
Mean corpuscular volume, fL (range)   101.5 (84.2-123.5)   98.5 (77.2-118.0)   .13  
Median platelet count, × 109/L (range)   14.0 (2.0-60.0)   16.0 (1.0-87.0)   .65  
Median reticulocyte count, × 109/L (range)   19.0 (3.0-90.0)   24.0 (2.0-106.0)   .50  
Median time from diagnosis to IST, d (range)   30 (1-334)   33 (2-268)   .46  
No. of patients who received G-CSF during IST
 
25
 
12
 
.94
 



PNH+

PNH-

P
No. of patients   83   39   NA  
Median age, y (range)   57 (13-83)   54 (12-83)   .16  
Sex, M/F   36/47   19/20   .58  
Severity, severe/moderate   53/30   22/17   .43  
Chromosome abnormality, no. of patients  7   3   .88  
   –7   0   1   
   +8   2   1   
   –Y   3   0   
   Others   2   1   
Median WBC count, × 109 (range)   2.1 (0.5-4.3)   1.9 (0.7-3.2)   .15  
Median neutrophil count, × 109/L (range)   0.53 (0.02-2.2)   0.49 (0.01-2.7)   .65  
Median hemoglobin level, g/L (range)   67 (32-140)   67 (40-108)   .92  
Mean corpuscular volume, fL (range)   101.5 (84.2-123.5)   98.5 (77.2-118.0)   .13  
Median platelet count, × 109/L (range)   14.0 (2.0-60.0)   16.0 (1.0-87.0)   .65  
Median reticulocyte count, × 109/L (range)   19.0 (3.0-90.0)   24.0 (2.0-106.0)   .50  
Median time from diagnosis to IST, d (range)   30 (1-334)   33 (2-268)   .46  
No. of patients who received G-CSF during IST
 
25
 
12
 
.94
 

NA indicates not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal